Tandem Diabetes Care releases Q4/FY2024 earnings; financial figures not provided in filing excerpt

TANDEM DIABETES CARE INC

2024-FY EPS reported -$1.47 revenue$940,203,000

Company issued press release on February 26, 2025 for Q4 and full year 2024 results.
No specific financial data (revenue, EPS, etc.) is available in the 8-K excerpt; exhibit 99.1 is not fully included.
Refer to the full press release for detailed results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.